A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment

A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment - A study of the endovascular treatment after intravenous t-PA treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004860

Enrollment

Registered

2011-02-01

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction within onset three hours

Interventions

endovascular treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A case with main cerebral artery (ICA, MCA, VA, BA) occlusion who has administered iv-tPA within three hours onset

Exclusion criteria

Exclusion criteria: The patient having contrast media allergy contraindication for iv-tPA treatment

Design outcomes

Primary

Measure	Time frame
Number of patients that modified Rankin's scale onset three months later is 0 to 2.	—

Secondary

Measure	Time frame
Symptomatic intracranial hemorrhage within onset of 24 hours Death within onset three months Presence of recanalization just after the endovascular treatment NIHSS score: after treatment of 24 hours, 7days, and discharge Other adverse effect	—

Countries

Japan

Contacts

Public ContactMasao Watanabe

Kawasaki Medical School Department of stroke medicine

masao-w@par.odn.ne.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026